000 01526 a2200421 4500
005 20250515073424.0
264 0 _c20070904
008 200709s 0 0 eng d
022 _a1744-8344
024 7 _a10.1586/14779072.5.4.753
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPatnaik, Mrinal M
245 0 0 _aPregnancy and thrombophilia.
_h[electronic resource]
260 _bExpert review of cardiovascular therapy
_cJul 2007
300 _a753-65 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntithrombin III Deficiency
_xphysiopathology
650 0 4 _aBlood Circulation
_xphysiology
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHeparin, Low-Molecular-Weight
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPlacenta
_xblood supply
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Hematologic
_xdrug therapy
650 0 4 _aPregnancy Outcome
650 0 4 _aPregnancy Trimester, Second
650 0 4 _aPregnancy Trimester, Third
650 0 4 _aPuerperal Disorders
_xphysiopathology
650 0 4 _aPulmonary Embolism
_xphysiopathology
650 0 4 _aThrombophilia
_xdrug therapy
650 0 4 _aVena Cava Filters
650 0 4 _aVenous Thrombosis
_xphysiopathology
700 1 _aHaddad, Tufia
700 1 _aMorton, Colleen T
773 0 _tExpert review of cardiovascular therapy
_gvol. 5
_gno. 4
_gp. 753-65
856 4 0 _uhttps://doi.org/10.1586/14779072.5.4.753
_zAvailable from publisher's website
999 _c17141942
_d17141942